Perceptions of breast cancer and experience of side-effects by breast cancer survivors prescribed tamoxifen and aromatase inhibitors

被引：0
|
作者：
Hughes, Lyndsay [1 ]
Moss-Morris, Rona [1 ]
Hunter, Myra [1 ]
Norton, Sam [1 ]
Moon, Zoe [1 ]
机构：
[1] Kings Coll London, Hlth Psychol Sect, London, England
来源：
PSYCHO-ONCOLOGY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors
    Xiaoqing Xu
    Rowan T. Chlebowski
    Jiaxiao Shi
    Ana Barac
    Reina Haque
    Breast Cancer Research and Treatment, 2019, 174 : 785 - 794
  • [42] Aromatase inhibitors in breast cancer
    Brodie, A
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) : 61 - 65
  • [43] Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitors
    Sestak, Ivana
    Cuzick, Jack
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 425 - 432
  • [44] Tamoxifen decreases breast cancer risk but with side effects
    Reactions Weekly, 2003, 937 (1) : 5 - 5
  • [45] Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study
    Blaes, Anne
    Beckwith, Heather
    Florea, Natalia
    Hebbel, Robert
    Solovey, Anna
    Potter, David
    Yee, Douglas
    Vogel, Rachel
    Luepker, Russell
    Duprez, Daniel
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (02) : 541 - 547
  • [46] Cognitive Function in Relation to Aromatase Inhibitors among Breast Cancer Survivors
    Fersis, N.
    Humenikova, M.
    Stachurova, M.
    Schmidt, M.
    Popovic, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 53 - 53
  • [47] Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study
    Anne Blaes
    Heather Beckwith
    Natalia Florea
    Robert Hebbel
    Anna Solovey
    David Potter
    Douglas Yee
    Rachel Vogel
    Russell Luepker
    Daniel Duprez
    Breast Cancer Research and Treatment, 2017, 166 : 541 - 547
  • [48] Aromatase inhibitors in the adjuvant treatment of early breast cancer - Is there still a place for tamoxifen?
    Bergerat, Jean-Pierre
    PRESSE MEDICALE, 2007, 36 (02): : 333 - 340
  • [49] Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
    Dackus, Gwen M. H. E.
    Jozwiak, Katarzyna
    Sonke, Gabe S.
    van der Wall, Elsken
    van Diest, Paul J.
    Siesling, Sabine
    Hauptmann, Michael
    Linn, Sabine C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (11): : 1506 - 1514
  • [50] Aromatase inhibitors declared superior to tamoxifen in the adjuvant treatment of early breast cancer
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (09): : 1104 - 1105
12345